{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":41,"description":"8 mg ondansetron given IV prior to Cycle 1 of Cisplatin then 34.3 mg granisetron patch applied and then reapplied every 7 days prior to Cycles 2-5 of Cisplatin.","id":"EG000","otherNumAffected":15,"otherNumAtRisk":41,"seriousNumAffected":0,"seriousNumAtRisk":41,"title":"Arm 1: Transdermal Granisetron"},{"deathsNumAffected":0,"deathsNumAtRisk":34,"description":"8 mg ondansetron given IV prior to Cycles 1-5 then 8 mg oral ondansetron every 8 hours for 72 hours following each Cisplatin and PRN in-between cycles.","id":"EG001","otherNumAffected":12,"otherNumAtRisk":34,"seriousNumAffected":0,"seriousNumAtRisk":34,"title":"Arm 2: Oral Ondansetron"}],"frequencyThreshold":"3","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":41},{"groupId":"EG001","numAffected":6,"numAtRisk":34}],"term":"Constipation"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":41},{"groupId":"EG001","numAffected":3,"numAtRisk":34}],"term":"Diarrhea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":15,"numAtRisk":41},{"groupId":"EG001","numAffected":12,"numAtRisk":34}],"term":"Nausea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"CTCAE (4.0)","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":41},{"groupId":"EG001","numAffected":10,"numAtRisk":34}],"term":"Fatigue"}],"timeFrame":"Baseline through 7 days for each chemotherapy cycle, an average of 6 weeks"}